GRISEOFULVIN, 125mg, tab.

STD DORAGRIS1T-

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.3 - Antifungal medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
D01BA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

GRISEOFULVIN

Therapeutic Action

Indications

Dermatophyte infections of the scalp (scalp ringworm)

Dermatophyte infections of the skin and folds, in case of extended lesions or if the topical treatment has failed

Instructions for use

The 125 mg dosage is intended for paediatric use.

Precautions for Use

Contraindicated in pregnancy and breast-feeding: apply a topical treatment (miconazole 2% cream).

Storage

Below 25°C - Protect from sunlight - Protect from humidity